1. Home
  2. EDBL vs VRAX Comparison

EDBL vs VRAX Comparison

Compare EDBL & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EDBL

Edible Garden AG Incorporated

HOLD

Current Price

$0.89

Market Cap

1.8M

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$1.40

Market Cap

1.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDBL
VRAX
Founded
2020
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.5M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
EDBL
VRAX
Price
$0.89
$1.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 288.6K
153.4K
Earning Date
11-13-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $12,810,000.00
N/A
Revenue This Year
$24.00
N/A
Revenue Next Year
$282.47
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.08
$0.10
52 Week High
$18.90
$13.19

Technical Indicators

Market Signals
Indicator
EDBL
VRAX
Relative Strength Index (RSI) 21.42 25.88
Support Level $0.88 $0.16
Resistance Level $1.20 $3.01
Average True Range (ATR) 0.06 0.29
MACD -0.01 -0.05
Stochastic Oscillator 3.33 6.97

Price Performance

Historical Comparison
EDBL
VRAX

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces. Company provides two principal product segments: (i) fresh produce, including cut herbs, hydroponic basil, potted herbs, and wheatgrass; and (ii) shelf-stable and refrigerated consumer packaged goods, including sports nutrition and nutraceuticals.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: